254 related articles for article (PubMed ID: 29786922)
1. Finding factors that predict treatment-resistant depression: Results of a cohort study.
Cepeda MS; Reps J; Ryan P
Depress Anxiety; 2018 Jul; 35(7):668-673. PubMed ID: 29786922
[TBL] [Abstract][Full Text] [Related]
2. Treatment resistant depression in women with peripartum depression.
Cepeda MS; Kern DM; Nicholson S
BMC Pregnancy Childbirth; 2019 Sep; 19(1):323. PubMed ID: 31477032
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant resistance in adolescents with major depressive disorder: A nationwide longitudinal study.
Chen LC; Chen YH; Bai YM; Chen TJ; Chen MH; Su TP
J Affect Disord; 2020 Feb; 262():293-297. PubMed ID: 31733920
[TBL] [Abstract][Full Text] [Related]
4. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
[TBL] [Abstract][Full Text] [Related]
5. Substance use disorders and risk for treatment resistant depression: a population-based, nested case-control study.
Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Addiction; 2020 Apr; 115(4):768-777. PubMed ID: 31656053
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder.
Zhdanava M; Kuvadia H; Joshi K; Daly E; Pilon D; Rossi C; Morrison L; Lefebvre P; Nelson C
Curr Med Res Opin; 2021 Jan; 37(1):123-133. PubMed ID: 33124940
[TBL] [Abstract][Full Text] [Related]
7. Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.
Cepeda MS; Reps J; Fife D; Blacketer C; Stang P; Ryan P
Depress Anxiety; 2018 Mar; 35(3):220-228. PubMed ID: 29244906
[TBL] [Abstract][Full Text] [Related]
8. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
9. Socio-demographic and clinical risk factors of treatment-resistant depression: A Danish population-based cohort study.
Gronemann FH; Jorgensen MB; Nordentoft M; Andersen PK; Osler M
J Affect Disord; 2020 Jan; 261():221-229. PubMed ID: 31655377
[TBL] [Abstract][Full Text] [Related]
10. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.
Lähteenvuo M; Taipale H; Tanskanen A; Rannanpää S; Tiihonen J
J Affect Disord; 2022 Jul; 308():236-242. PubMed ID: 35398108
[TBL] [Abstract][Full Text] [Related]
11. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.
Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
Acta Psychiatr Scand; 2019 Jan; 139(1):78-88. PubMed ID: 30291625
[TBL] [Abstract][Full Text] [Related]
12. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.
Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N
PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694
[TBL] [Abstract][Full Text] [Related]
13. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
[TBL] [Abstract][Full Text] [Related]
14. Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.
Huang SS; Chen HH; Wang J; Chen WJ; Chen HC; Kuo PH
BMC Psychiatry; 2020 Nov; 20(1):541. PubMed ID: 33203427
[TBL] [Abstract][Full Text] [Related]
15. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans.
Joshi K; Pilon D; Shah A; Holiday C; Karkare S; Zhdanava M
J Med Econ; 2023; 26(1):422-429. PubMed ID: 36924214
[TBL] [Abstract][Full Text] [Related]
17. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH
J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174
[TBL] [Abstract][Full Text] [Related]
18. Prospective Service Use and Health Care Costs of Medicaid Beneficiaries with Treatment-Resistant Depression.
Olfson M; Amos TB; Benson C; McRae J; Marcus SC
J Manag Care Spec Pharm; 2018 Mar; 24(3):226-236. PubMed ID: 29485948
[TBL] [Abstract][Full Text] [Related]
19. Economic impact of treatment-resistant depression: A retrospective observational study.
Pérez-Sola V; Roca M; Alonso J; Gabilondo A; Hernando T; Sicras-Mainar A; Sicras-Navarro A; Herrera B; Vieta E
J Affect Disord; 2021 Dec; 295():578-586. PubMed ID: 34509073
[TBL] [Abstract][Full Text] [Related]
20. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
